Misonix Expands Ultrasonic Technology Capabilities to Address the Orthoplastics Market

Misonix SonicOne Hero

Misonix expanded its capabilities to address the orthoplastics market by incorporating its Sequel line of external fixators as a complement to its existing wound debridement and regenerative products.

The company markets BoneScalpel and SonaStar to facilitate precise bone sculpting and removal of soft and hard tumors and tissue, with...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us